A detailed history of Graney & King, LLC transactions in Viatris Inc stock. As of the latest transaction made, Graney & King, LLC holds 174 shares of VTRS stock, worth $1,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174
Previous 221 21.27%
Holding current value
$1,734
Previous $1.92 Million 19.34%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$7.26 - $9.12 $341 - $428
-47 Reduced 21.27%
174 $1.55 Million
Q1 2025

May 14, 2025

BUY
$8.68 - $12.42 $8 - $12
1 Added 0.45%
221 $1.92 Million
Q4 2024

Feb 11, 2025

BUY
$11.32 - $13.37 $2,490 - $2,941
220 New
220 $2.74 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Graney & King, LLC Portfolio

Follow Graney & King, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graney & King, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graney & King, LLC with notifications on news.